Parisa Sharafi
Overview
Explore the profile of Parisa Sharafi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bayrak H, Sharafi P, Ozketen A, Kilic M
Postgrad Med J
. 2025 Jan;
PMID: 39764669
Metabolism is the name given to all of the chemical reactions in the cell involving thousands of proteins, including enzymes, receptors, and transporters. Inborn errors of metabolism (IEM) are caused...
2.
Sharafi P, Varan A, Ersoy-Evans S, Ayter S
Childs Nerv Syst
. 2023 Jul;
40(2):511-515.
PMID: 37401974
Purpose: Optic pathway gliomas (OPGs) occur in 15% of patients with neurofibromatosis type 1 (NF1). Their location renders biopsy or surgical resection difficult because of the risk of vision loss....
3.
Kucukkaya Eren S, Bahador Zirh E, Zirh S, Sharafi P, Zeybek N
J Appl Oral Sci
. 2022 Sep;
30:e20220086.
PMID: 36102412
Background: Bioactive molecules present the potential to be used along with biomaterials in vital pulp therapy and regenerative endodontic treatment. Objective: The aim of this study was to assess the...
4.
Aerts-Kaya F, Koca G, Sharafi P, Sayla F, Uckan-Cetinkaya D, Ozdemir E
Bone Marrow Transplant
. 2018 Apr;
53(9):1225-1227.
PMID: 29703970
No abstract available.
5.
Sharafi P, Ayter S
J Neurogenet
. 2018 Apr;
32(2):65-77.
PMID: 29644913
Neurofibromatosis type 1 (NF1) is the most common neurogenetic disorder worldwide, caused by mutations in the (NF1) gene. Although NF1 is a single-gene disorder with autosomal-dominant inheritance, its clinical expression...
6.
Igci N, Sharafi P, Ozel Demiralp D, Demiralp C, Yuce A, Dokmeci Emre S
Adv Clin Exp Med
. 2017 Dec;
26(7):1053-1061.
PMID: 29211351
Background: Gaucher disease (GD) is defined as an autosomal recessive disorder resulting from the deficiency of glucocerebrosidase (E.C. 3.2.1.45). Glucocerebrosidase is responsible for the degradation of glucosylceramide into ceramide and...
7.
Sharafi P, Kocaefe Y
Protein Pept Lett
. 2016 Apr;
23(6):530-6.
PMID: 27064098
Mammalian cells are widely used for recombinant protein production in research and biotechnology. Utilization of export signals significantly facilitates production and purification processes. 35 years after the discovery of the...
8.
Ozdemir C, Akpulat U, Sharafi P, Yildiz Y, Onbasilar I, Kocaefe C
Gene
. 2014 Oct;
553(2):130-9.
PMID: 25303869
The transcriptional events and pathways responsible for the acquisition of the myogenic phenotype during regeneration and myogenesis have been studied extensively. The modulators that shape the extracellular matrix in health...
9.
Kayman-Kurekci G, Talim B, Korkusuz P, Sayar N, Sarioglu T, Oncel I, et al.
Neuromuscul Disord
. 2014 May;
24(7):624-33.
PMID: 24856141
We performed genome-wide homozygosity mapping and mapped a novel myopathic phenotype to chromosomal region 1q25 in a consanguineous family with three affected individuals manifesting proximal and distal weakness and atrophy,...